IP Library Granted Patent US 7,601,841
Granted Patent B2
US 7,601,841 · App. 10/719,997 · Granted Oct 13, 2009

Quinolinyl and benzothiazolyl modulators

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,601,841
App. No.
10/719,997
Granted
Oct 13, 2009
Kind
B2
Abstract

Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPARγ. In particular, the compounds of the invention modulate the function of PPARγ. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.

Claims (38)

1. A compound having the formula:

wherein

A is Cl or CF 3 ;

C is Cl or CF 3 ;

D is H or CH 3 ;

V is F or Cl;

X is a member selected from the group consisting of H, CH 3 , COOH, and CO 2 CH 3 ; and

Y is a member selected from the group consisting of H, CO 2 H and CO 2 CH 3 ;

or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1 , wherein V is Cl.

3. The compound of claim 1 , wherein X and Y are each H.

4. The compound of claim 1 , wherein A is Cl.

5. The compound of claim 1 , wherein A is CF 3 .

6. The compound of claim 1 , wherein D is H.

7. The compound of claim 1 , wherein A is Cl and D is H.

8. The compound of claim 1 , wherein A is Cl; C is Cl; and V is Cl.

9. The compound of claim 1 , wherein C is CF 3 .

10. The compound of claim 1 , wherein A is Cl; C is Cl; V is Cl, D is CH 3 , and X and Y are each H.

11. The compound of claim 1 , wherein A is Cl; C is Cl; V is Cl, D is H, and X and Y are each H.

12. A composition comprising a pharmaceutically acceptable carrier or excipient and a compound having the formula:

wherein

A is Cl or CF 3 ;

C is Cl or CF 3 ;

D is H or CR 3 ;

V is F or Cl;

X is a member selected from the group consisting of H, CH 3 , COOH, and CO 2 CH 3 ; and

Y is a member selected from the group consisting of H, CO 2 H and CO 2 CH 3 ;

or a pharmaceutically acceptable salt thereof.

13. The composition of claim 12 , wherein V is Cl.

14. The composition of claim 12 , wherein X and Y are each H.

15. The composition of claim 12 , wherein A is Cl.

16. The composition of claim 12 , wherein A is CF 3 .

17. The composition of claim 12 , wherein D is H.

18. The composition of claim 12 , wherein A is Cl and D is H.

19. The composition of claim 12 , wherein A is Cl; C is Cl; and V is Cl.

20. The composition of claim 12 , wherein C is CF 3 .

21. The composition of claim 12 , wherein A is Cl; C is Cl; V is Cl, D is CH 3 , and X and Y are each H.

22. The composition of claim 12 , wherein A is Cl; C is Cl; V is Cl, D is H, and X and Y are each H.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2005
From: AMGEN SF, LLC
To: AMGEN INC.
Reel/Frame 016871/0736 →
MERGER Recorded Jun 7, 2005
From: TULARIK INC.
To: ARROW ACQUISITION, LLC
Reel/Frame 016309/0003 →
CHANGE OF NAME Recorded Jun 7, 2005
From: ARROW ACQUISITION, LLC
To: AMGEN SF, LLC
Reel/Frame 016309/0812 →